Epigenetic drugs in cancer therapy

Cancer and Metastasis Reviews · Published 2025-01-01 · Journal article · DOI 10.1007/s10555-025-10253-7 · Cited by 102 (Crossref)

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s10555-025-10253-7

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Menin inhibitors for adult acute myeloid leukemia: 2025 update · Expert Opinion on Investigational Drugs · 2025 · Cites or is cited by this article
• Using ultrasound and microbubble to enhance the effects of conventional cancer therapies in clinical settings · Cancer and Metastasis Reviews · 2025 · Same journal
• CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting · Cancer and Metastasis Reviews · 2025 · Same journal
• Neuronal mimicry in tumors: lessons from neuroscience to tackle cancer · Cancer and Metastasis Reviews · 2025 · Same journal
• Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy · Cancer and Metastasis Reviews · 2025 · Same journal
• Mitochondrial alterations and signatures in hepatocellular carcinoma · Cancer and Metastasis Reviews · 2025 · Same journal
• p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair · Cancer and Metastasis Reviews · 2025 · Same journal
• The functions and modifications of tRNA-derived small RNAs in cancer biology · Cancer and Metastasis Reviews · 2025 · Same journal
• Ferroptosis: iron release mechanisms in the bioenergetic process · Cancer and Metastasis Reviews · 2025 · Same journal
• Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis · Cancer and Metastasis Reviews · 2025 · Same journal

Metrics

Citations (Crossref)

102